Medistim Asa Stock Five Year Return
MEDI Stock | NOK 154.00 0.50 0.32% |
Medistim ASA fundamentals help investors to digest information that contributes to Medistim ASA's financial success or failures. It also enables traders to predict the movement of Medistim Stock. The fundamental analysis module provides a way to measure Medistim ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medistim ASA stock.
Medistim |
Medistim ASA Company Five Year Return Analysis
Medistim ASA's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Medistim ASA Five Year Return | 2.62 % |
Most of Medistim ASA's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medistim ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Medistim ASA has a Five Year Return of 2.62%. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The five year return for all Norway stocks is notably lower than that of the firm.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
Medistim Fundamentals
Return On Equity | 0.31 | |||
Return On Asset | 0.2 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 4.12 B | |||
Shares Outstanding | 18.26 M | |||
Shares Owned By Insiders | 14.97 % | |||
Shares Owned By Institutions | 73.95 % | |||
Price To Earning | 36.32 X | |||
Price To Book | 12.24 X | |||
Price To Sales | 9.15 X | |||
Revenue | 417.82 M | |||
Gross Profit | 320.7 M | |||
EBITDA | 137.68 M | |||
Net Income | 90.9 M | |||
Cash And Equivalents | 129.49 M | |||
Cash Per Share | 2.99 X | |||
Total Debt | 17.08 M | |||
Debt To Equity | 3.40 % | |||
Current Ratio | 3.68 X | |||
Book Value Per Share | 18.94 X | |||
Cash Flow From Operations | 128.14 M | |||
Earnings Per Share | 5.34 X | |||
Target Price | 290.0 | |||
Number Of Employees | 116 | |||
Beta | 0.75 | |||
Market Capitalization | 4.24 B | |||
Total Asset | 403.24 M | |||
Working Capital | 93 M | |||
Current Asset | 136 M | |||
Current Liabilities | 43 M | |||
Annual Yield | 0.02 % | |||
Five Year Return | 2.62 % | |||
Net Asset | 403.24 M | |||
Last Dividend Paid | 3.75 |
About Medistim ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medistim ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medistim ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medistim ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.